Search Results - "Pechery, Adeline"

Molecular and nanoscale evaluation of N-cadherin expression in invasive bladder cancer cells under control conditions or GW501516 exposure by Elie-Caille, Céline, Lascombe, Isabelle, Péchery, Adeline, Bittard, Hugues, Fauconnet, Sylvie

“…N-cadherin is a transmembrane glycoprotein expressed by mesenchymal origin cells and is located at the adherens junctions. It regulates also cell motility and…”
Get full text

GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells by Barbaud, Alexandre, Lascombe, Isabelle, Péchery, Adeline, Arslan, Sergen, Kleinclauss, François, Fauconnet, Sylvie

“…Bladder cancer aggressiveness is correlated with abnormal N-cadherin transmembrane glycoprotein expression. This protein is cleaved by the metalloprotease…”
Get full text

Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells by Péchery, Adeline, Fauconnet, Sylvie, Bittard, Hugues, Lascombe, Isabelle

“…GW501516 is a selective and high-affinity synthetic agonist of peroxisome proliferator-activated receptor β/δ (PPARβ/δ). This molecule promoted the inhibition…”
Get full text

Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC by Sun, Xu Shan, Michel, Cécile, Babin, Emmanuel, De Raucourt, Dominique, Péchery, Adeline, Gherga, Elisabeta, Géry, Bernard, Florescu, Carmen, Bourhis, Jean, Thariat, Juliette

“…Median survival for recurrent/metastatic head and neck squamous cell cancer (HNSCC) patients is about 10 months after first-line best systemic treatment. We…”
Get full text

Standard versus fractionated high-dose cisplatin plus radiation for locally advanced head and neck cancer: Results of the CisFRad (GORTEC 2015-02) randomized phase II trial by Borel, Christian, Sun, Xu-Shan, Coutte, Alexandre, Bera, Guillaume, Sire, Christian, Zanetta, Sylvie, Alfonsi, Marc, Janoray, Guillaume, Chatellier, Thierry, Garcia-Ramirez, Muriel, Gherga, Elisabeta, Hammoud, Yasser, Burgy, Mickaël, Etienne-Selloum, Nelly, Pechery, Adeline, Girard-Calais, Marie-Hélène, Velten, Michel, Pignon, Jean-Pierre, Wanneveich, Mathilde, Bourhis, Jean

“…•The 4-day fractionated regimen allows significantly more patients to receive a third cycle of cisplatin, with fewer dose reductions than the standard regimen…”
Get full text

Apoptotic effect of the selective PPAR[beta]/[delta] agonist GW501516 in invasive bladder cancer cells by Péchery, Adeline, Fauconnet, Sylvie, Bittard, Hugues, Lascombe, Isabelle

“…GW501516 is a selective and high-affinity synthetic agonist of peroxisome proliferator-activated receptor [beta]/δ (PPAR[beta]/δ). This molecule promoted the…”
Get full text